Reply to Oegema et al.: CFI-400945 and Polo-like kinase 4 inhibition [Biological Sciences]

In "CFI-400945 is not a selective cellular PLK4 inhibitor," Oegema et al. (1) raise thoughtful comments about our article (2). We appreciate their interest and critique. They propose that CFI-400945 activity was not from Polo-like kinase (PLK4) inhibition and argue that antineoplastic activity was through Aurora B kinase (1), rather...

https://ift.tt/2Flvsa1